Bradbury Daniel's Form 4 filing
Castle Biosciences Inc (CSTL) · filed Mar 6, 2023
- Accession no.
- 0001447362-23-000046
- Filed
- Mar 6, 2023
- Trade date
- Mar 2-3, 2023
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 9 non-derivative transactions. Open-market sales total $599.3K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Bradbury DanielCIK 0001236397 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 2, 2023 | Common Stock | SSaleDisposed | −4,559 | $23.16F2 | −$105,586.44 | 179,980 | Indirect | |
| Mar 2, 2023 | Common Stock | SSaleDisposed | −1,520 | $23.16F2 | −$35,203.2 | 91,260 | Indirect | |
| Mar 2, 2023 | Common Stock | SSaleDisposed | −1,519 | $23.16F2 | −$35,180.04 | 91,286 | Indirect | |
| Mar 2, 2023 | Common Stock | SSaleDisposed | −2,250 | $23.58F6 | −$53,055 | 177,730 | Indirect | |
| Mar 2, 2023 | Common Stock | SSaleDisposed | −750 | $23.58F6 | −$17,685 | 90,510 | Indirect | |
| Mar 2, 2023 | Common Stock | SSaleDisposed | −751 | $23.58F6 | −$17,708.58 | 90,535 | Indirect | |
| Mar 3, 2023 | Common Stock | SSaleDisposed | −8,191 | $24.53F7 | −$200,925.23 | 169,539 | Indirect | |
| Mar 3, 2023 | Common Stock | SSaleDisposed | −2,730 | $24.53F7 | −$66,966.9 | 87,780 | Indirect | |
| Mar 3, 2023 | Common Stock | SSaleDisposed | −2,730 | $24.53F7 | −$66,966.9 | 87,805 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $22.515 to $23.510, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 3 transactions in Table I.
- F6
This transaction was executed in multiple trades at prices ranging from $23.520 to $23.740, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 3 transactions in Table I.
- F7
This transaction was executed in multiple trades at prices ranging from $23.965 to $24.810, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 3 transactions in Table I.